Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Associations between genetically predicted plasma protein levels and Alzheimer’s disease risk: a study using genetic prediction models

11 Jan 2024

Abstract excerpt

BACKGROUND: Specific peripheral proteins have been implicated to play an important role in the development of Alzheimer's disease (AD). However, the roles of additional novel protein biomarkers in AD etiology remains elusive. The availability of large-scale AD GWAS and plasma proteomic data provide the resources needed for the identification of causally relevant circulating proteins that may serve as risk factors...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Genetic Associations and Epidemiology
Share to Metabolomics and Mass Spectrometry Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38212844
DOI: 10.1186/s13195-023-01378-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Associations between genetically predicted plasma protein levels and Alzheimer’s disease risk: a study using genetic prediction modelsPMID 38212844Read ↗

Proteome-wide association study identifies novel Alzheimer's disease- associated proteinsSemantic proximity Read ↗

Novel Plasma Proteins Associated With Alzheimer’s Disease Risk in APOE ε4 Carriers and Non-carriersSemantic proximity Read ↗

Degree of genetic liability for Alzheimer's disease associated with specific proteomic profiles in cerebrospinal fluid.Semantic proximity Read ↗

A genetic and proteomic comparison of key AD biomarkers across tissuesSemantic proximity Read ↗

Biomarker identification for Alzheimer's disease through integration of comprehensive Mendelian randomization and proteomics data.Semantic proximity Read ↗

Plasma protein biomarkers of Alzheimer’s disease endophenotypes in asymptomatic older twins: early cognitive decline and regional brain volumesSemantic proximity Read ↗

Assessing genetic overlap and causality between blood plasma proteins and Alzheimer’s DiseaseSemantic proximity Read ↗

Identification of potential therapeutic targets for Alzheimer's disease from the proteomes of plasma and cerebrospinal fluid in a multicenter Mendelian randomization studySemantic proximity Read ↗

Can Genetic Markers Predict the Sporadic Form of Alzheimer's Disease? An Updated Review on Genetic Peripheral Markers.Semantic proximity Read ↗

Identification of Blood Biomarkers for Alzheimer's Disease Through Computational Prediction and Experimental ValidationSemantic proximity Read ↗

Multivariate proteome-wide association study to identify causal proteins for Alzheimer disease.Semantic proximity Read ↗

A Mendelian randomization study identifies proteins involved in neurodegenerative diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.